10x Genomics, Inc. - CLASS A COMMON STOCK (TXG)

CUSIP: 88025U109

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / CLASS A COMMON STOCK
Shares outstanding
118,868,985
Total 13F shares
77,884,791
Share change
+7,712,824
Total reported value
$15,246,137,868
Put/Call ratio
18%
Price per share
$195.82
Number of holders
332
Value change
+$1,517,689,271
Number of buys
213
Number of sells
112

Quarterly Holders Quick Answers

What is CUSIP 88025U109?
CUSIP 88025U109 identifies TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q2 2021

As of 30 Jun 2021, 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) was held by 332 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 77,884,791 shares. The largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, BAILLIE GIFFORD & CO, MORGAN STANLEY, ARK Investment Management LLC, 12 West Capital Management LP, Meritech Capital Associates V L.L.C., Foresite Capital Management II, LLC, and Sumitomo Mitsui Trust Holdings, Inc.. This page lists 332 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.